Type
. Pathogenesis of a Third World disease: lessons from leprosy. Harvey lectures. 1988;84:41-63.
Type
. Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1988;82(6):810-7.
Type
. Reconstructing the epidemiology of medieval leprosy: preliminary efforts with regard to Scandinavia. Perspectives in biology and medicine. 1988;31(4):496-506.
Type
. The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1987;55(4 Suppl):807-13.
Type
. A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients. Leprosy review [Internet]. 1987;58(4):389-400. Available from: http://leprev.ilsl.br/pdfs/1987/v58n4/pdf/v58n4a08.pdf
Type
. Etiological factors in delayed-type hypersensitivity reactions in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1987;55(4):702-12.
Type
. Gamma interferon production induced by antigens in patients with leprosy and American cutaneous leishmaniasis. The American journal of tropical medicine and hygiene. 1987;37(3):520-4.
Type
. Mycobacterial carbohydrate antigens for serological testing of patients with leprosy. The Journal of infectious diseases. 1987;156(5):763-9.
Type
. [Being a nurse is beautiful]. Professioni infermieristiche. 1987;40(4):370-5.
Type
. Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies. Journal of immunology (Baltimore, Md. : 1950). 1987;139(7):2496-501.